Funded Startups in Heidelberg
Among the disclosed rounds, Affimed’s $90M (2022-04-13) is the only entry far above the rest, with the next-largest disclosed amounts at $63M (Getsafe, 202…
Among the disclosed rounds, Affimed’s $90M (2022-04-13) is the only entry far above the rest, with the next-largest disclosed amounts at $63M (Getsafe, 2021-10-06) and $59M (Exciva, 2026-01-20). The size distribution is otherwise compressed between $27M and $6M, while the smallest disclosed round is Musaic’s $100K (2021-02-15), a clear low-end outlier in a different stage.
The temporal spread runs from 2021-02-15 to 2026-07-23, and most of the most recent activity clusters in the last ~20 months (2024-04-11 through 2026-07-23). Sector-wise, Biotechnology (Exciva on 2026-01-20; Living Brain on 2022-07-11; Affimed on 2022-04-13) appears in multiple entries, alongside multiple AI entries (kausable on 2026-07-23; paretos on 2024-10-28; Paicon on 2022-11-22; Aleph Alpha on 2021-07-27; Novaliq on 2022-04-12). All entries list Heidelberg, Germany, repeatedly across both early-stage and large disclosed rounds.
Most recent rounds
18 shownRelated listings
Frequently asked
How does the largest disclosed round in Heidelberg compare to the rest of the disclosed amounts?
Affimed’s $90M (2022-04-13) is the standout top figure; the next-largest disclosed rounds are Getsafe at $63M (2021-10-06) and Exciva at $59M (2026-01-20). After those, amounts step down to $27M (Aleph Alpha, 2021-07-27) and then mostly into the $15M–$6M band (e.g., Novaliq $15M on 2022-04-12 and Unikraft $6M on 2025-10-10).
Are there identifiable time clusters among the most recent 18 rounds?
Yes. Several rounds concentrate in the ~20 months ending with the latest entry: Unikraft (2025-10-10, $6M), Lillian Care (2025-10-13, undisclosed), kausable (2026-07-23, $14M), and Exciva (2026-01-20, $59M) sit after a 2024 run that includes paretos (2024-10-28, $9M), become.1 (2024-09-18, $4M), and Enzo (2024-07-12, $3M).
Which sectors are over-represented across these Heidelberg-funded companies?
Biotechnology shows up repeatedly: Exciva is labeled “Biotechnology” (2026-01-20, $59M), Living Brain is “Biotechnology” (2022-07-11, $2M), and Affimed is “Biotechnology” (2022-04-13, $90M). AI also appears across multiple entries: kausable (2026-07-23, $14M), paretos (2024-10-28, $9M), Paicon (2022-11-22, undisclosed), and Aleph Alpha (2021-07-27, $27M), plus Novaliq (2022-04-12, $15M).
Do any entries look like low-end or high-end outliers by disclosed amount?
On the high end, Affimed’s $90M (2022-04-13) dwarfs the next-largest disclosed amounts at $63M (Getsafe, 2021-10-06) and $59M (Exciva, 2026-01-20). On the low end, Musaic’s $100K (2021-02-15, Pre-Seed) is far below the surrounding disclosed figures such as $2M (Living Brain, 2022-07-11) and $3M (Enzo, 2024-07-12 is $3M but the row is dated 2024-07-12).
Is Heidelberg the dominant geography in this list, or are there cross-city patterns?
Every row lists Heidelberg, Germany, including multiple differently described address formats (e.g., “Heidelberg, Baden-Wurttemberg, Germany”). The city pattern is therefore tightly concentrated rather than spread across multiple cities, even when companies repeat the same city with different stages and sectors (e.g., Aleph Alpha at $27M on 2021-07-27 versus kausable at $14M on 2026-07-23).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.